← All Sponsors
SPONSOR

Uppsala University

Total Trials
11
Recruiting
11
Phases
Phase 2

Uppsala University is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Aortic Stenosis, Pancreatic Neuroendocrine Tumor, Breast Cancer, Breast Carcinoma in Situ.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Uppsala University

How many clinical trials has Uppsala University sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Uppsala University, of which 11 are actively recruiting participants. These trials cover conditions including Aortic Stenosis, Pancreatic Neuroendocrine Tumor, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Uppsala University research focus on?
Uppsala University clinical trials span Aortic Stenosis, Pancreatic Neuroendocrine Tumor, Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Invasive, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Uppsala University clinical trial?
To participate in a Uppsala University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Uppsala University trials with current recruitment status updated daily.

Clinical Trials by Uppsala University

NCT05629104
Recruiting

Prediction of Long-term Outcome in Aortic Stenosis After Valve Intervention

Aortic Stenosis
NCT07273409
Recruiting

Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not

Pancreatic Neuroendocrine Tumor
NCT06401304
Recruiting

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)

Breast Cancer
NCT03966716
Recruiting

Hips Screws or (Total) Hip Replacement for Undisplaced Femoral Neck Fractures in Elderly Patients (HipSTHeR)

Femoral Neck Fractures
NCT02797366 Phase 2
Recruiting

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults

Central Nervous System Tumour
NCT06446401
Recruiting

The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer

Prostate Cancer
NCT05300893
Recruiting

Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture

Dupuytren Contracture
NCT06307418
Recruiting

Internet-based Support for Informal Caregivers of Patients With Head and Neck Cancer - Carer eSupport

Head and Neck Cancer
NCT07461636
Recruiting

Robotic-Assisted Pedicle Screw Placement in Spine Surgery

Pedicle Screw Fixation of Spine
NCT07352683
Recruiting

Open TAP-block in Pediatric Abdominal Surgery

Pain Management After Surgery
NCT05763966
Recruiting

Uppsala Psychosis Cohort

Schizophrenia; Psychosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology